Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASLN | SLXN | ONCO | ||
| Company | Aslan Pharmaceuticals Ltd ADR | Silexion Therapeutics Corp | Onconetix Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.6300 | 3.21 | 1.0600 | ||
| High | 0.7000 | 3.21 | 1.1495 | ||
| Low | 0.6000 | 2.53 | 0.9903 | ||
| Latest | 0.6000 | 2.72 | 1.0850 | ||
| Change | -0.0999 | -0.41 | +0.0650 | ||
| % Change | -14.27% | -13.10% | +6.37% | ||
| Volume | 806,300 | 108,344 | 327,404 | ||
| 20-Day Average Volume | 289,117 | 1,813,228 | 1,516,218 | ||
| Previous Close | 0.6999 | 3.13 | 1.0200 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.0725 | 4.18 | 1.2116 | ||
| 20-Day Raw Stochastic | 5.23% | 3.63% | 5.94% | ||
| 20-Day Relative Strength | 25.90 | 32.28 | 28.75 | ||
| Weighted Alpha | -93.79 | -96.25 | -97.42 | ||
| Today's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -75.71% since 07/11/24 | -46.35% since 06/08/26 | +7.18% since 06/08/26 | ||
| Low | 0.4750 on 07/17/24 | 2.53 on 06/15/26 | 0.9242 on 06/10/26 | ||
| High | 2.7314 on 07/12/24 | 5.10 on 06/09/26 | 1.1500 on 06/15/26 | ||
| 1-Month | |||||
| %Chg | -75.97% since 06/18/24 | -7.27% since 05/15/26 | -71.06% since 05/15/26 | ||
| Low | 0.4750 on 07/17/24 | 2.53 on 06/15/26 | 0.9110 on 05/20/26 | ||
| High | 2.8640 on 06/21/24 | 6.66 on 05/20/26 | 3.8000 on 05/18/26 | ||
| 3-Month | |||||
| %Chg | -86.11% since 04/18/24 | -83.30% since 03/13/26 | -96.01% since 03/13/26 | ||
| Low | 0.4750 on 07/17/24 | 2.31 on 05/15/26 | 0.9110 on 05/20/26 | ||
| High | 4.8968 on 04/22/24 | 16.37 on 03/16/26 | 67.3000 on 03/27/26 | ||
| 6-Month | |||||
| %Chg | -85.84% since 01/18/24 | -89.61% since 12/15/25 | -98.90% since 12/15/25 | ||
| Low | 0.4750 on 07/17/24 | 2.31 on 05/15/26 | 0.9110 on 05/20/26 | ||
| High | 16.7200 on 03/12/24 | 26.93 on 12/17/25 | 115.0000 on 01/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,226 | 1,311 | 1,163 | ||
| Shares Outstanding, K | 2,044 | 419 | 1,140 | ||
| Annual Sales | 12,000,000 | 0 | 820,000 | ||
| Annual Net Income | -44,220,000 | -11,910,000 | -14,030,000 | ||
| Last Quarter Sales | 0 | 0 | 20,000 | ||
| Last Quarter Net Income | -9,920,000 | -2,730,000 | -4,210,000 | ||
| 60-Month Beta | 1.40 | -0.32 | 2.72 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -10.32 on 05/09/24 | -8.50 on 05/15/26 | -67.10 on 05/13/26 | ||
| Earnings Date | 08/09/24 | 08/11/26 | 08/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.02 | ||